“…Eruboside-B exhibited in-vitro cytotoxic activity against several cancer cell lines with the following ED 50 values (μg/mL): BC1 human breast cancer (3.6 μg/mL) Lu1 human lung cancer (1 μg/mL), Col2 human colon cancer (1 μg/ mL), KB human oral epidermoid cancer (12.7 μg/ mL), KB-V (+VLB) drug-resistant KB assessed in the presence of vinblastine (9 μg/mL) and KB-V (−VLB) and drug-resistant KB assessed in the absence of vinblastine (8.7 μg/mL). The results of in-vitro studies revealed that 95 % of HeLa cervical cancer cells were killed at a dose of 500 μL aqueous garlic extract, whereas about 92, 87, 60 and 24 % cancer cells were killed at doses of 400, 300, 200 or 100 μL of, respectively, Islam et al ( 2011 ).…”